ARQ (NASDAQ:ARQ) and Artemis Therapeutics (OTCMKTS:ATMS) Financial Review

ARQ (NASDAQ:ARQ) and Artemis Therapeutics (OTCMKTS:ATMS) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk and dividends.

Institutional & Insider Ownership

18.5% of ARQ shares are held by institutional investors. 22.2% of ARQ shares are held by company insiders. Comparatively, 7.5% of Artemis Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for ARQ and Artemis Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ARQ	0	0	0	0	N/A
Artemis Therapeutics	0	0	0	0	N/A

Volatility and Risk

ARQ has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Artemis Therapeutics has a beta of -1.92, suggesting that its stock price is 292% less volatile than the S&P 500.

Earnings and Valuation

This table compares ARQ and Artemis Therapeutics’ gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ARQ	$100.12 million	2.10	-$12.25 million	($0.27)	-21.59
Artemis Therapeutics	$310,000.00	0.76	-$1.36 million	N/A	N/A

Artemis Therapeutics has lower revenue, but higher earnings than ARQ.

Profitability

This table compares ARQ and Artemis Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ARQ	-8.15%	-4.65%	-3.51%
Artemis Therapeutics	-299.54%	N/A	-425.51%

Summary

ARQ beats Artemis Therapeutics on 7 of the 9 factors compared between the two stocks.

About ARQ

Arq, Inc. produces activated carbon products in North America. The company's products include granular activated carbon, powdered and granular activated carbon, and colloidal carbon products; Arq Powder Wetcake, a fine and low-ash coal waste-derived particle; and additives for air emissions control. Its products are used in various applications, including water treatment, ground water remediation, soil sediments, air emissions, and asphalt additives. The company was formerly known as Advanced Emissions Solutions, Inc. and changed its name to Arq, Inc. in February 2024. Arq, Inc. was founded in 1997 and is headquartered in Greenwood Village, Colorado.

About Artemis Therapeutics

Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.